R
Raffaele Bruno
Researcher at University of Pavia
Publications - 322
Citations - 14690
Raffaele Bruno is an academic researcher from University of Pavia. The author has contributed to research in topics: Medicine & Hepatitis C. The author has an hindex of 52, co-authored 275 publications receiving 11262 citations. Previous affiliations of Raffaele Bruno include University of Modena and Reggio Emilia.
Papers
More filters
Journal Article
Prioritization of high-cost new drugs for HCV: making sustainability ethical
Lucia Craxì,Dario Sacchini,Pietro Refolo,Roberta Minacori,Viviana Daloiso,Giovanna Ricci,Raffaele Bruno,Calogero Cammà,Americo Cicchetti,Antonio Gasbarrini,Antonio Gioacchino Spagnolo +10 more
TL;DR: An ethical assessment addressing the issues linked to access to new therapies, prioritization and eligibility criteria is performed, analyzing the meaning of the term "distributive justice" and the different approaches that can guide us (individualistic libertarianism, social utilitarianism and egalitarianism) on this specific matter.
Journal ArticleDOI
Acupressure on Self-Reported Sleep Quality During Pregnancy.
TL;DR: The study suggests that H7 acupression applied for 2 weeks improves sleep quality in pregnant women, and this preliminary result should serve to stimulate further studies on the long-term effects of acupress.
Journal ArticleDOI
Hepatotoxicity and nelfinavir: a meta-analysis.
TL;DR: The results indicate that among 4 commercially available protease inhibitors and a 2-protease inhibitor combination, nelfinavir and indinavir are associated with the lowest rates of occurrence of severe hepatotoxicity.
Journal ArticleDOI
Triple therapy with first-generation Protease Inhibitors for patients with genotype 1 chronic hepatitis C: Recommendations of the Italian Association for the Study of the Liver (AISF)
Barbara Coco,Paolo Caraceni,Alessio Aghemo,Davide Bitetto,Raffaele Bruno,Alessia Ciancio,Marco Marzioni,Salvatore Petta,Maria Rendina,Luca Valenti,Alfredo Alberti,Pietro Andreone,Ferruccio Bonino,Maurizia Rossana Brunetto,Savino Bruno,Massimo Colombo,Antonio Craxì,Giovanni Battista Gaeta,Alessandra Mangia,Massimo Puoti,Mario Rizzetto,Maria Grazia Rumi +21 more
TL;DR: The first-generation Protease Inhibitors Boceprevir and Telaprevir administered in triple therapy regimens with Peg-interferon alpha and Ribavirin have been proven effective in increasing the rate of Sustained Virological Response in both naive and treatment-experienced patients with chronic genotype-1 hepatitis C.
Journal ArticleDOI
Quantification of HIV-1 proviral DNA in patients with undetectable plasma viremia over long-term highly active antiretroviral therapy.
M. Debiaggi,Francesca Zara,Angela Pistorio,Raffaele Bruno,Paolo Sacchi,S.F.A. Patruno,G. Achilli,Egidio Romero,Gaetano Filice +8 more
TL;DR: Assessment of the prognostic role of proviral DNA in peripheral blood mononuclear cells of patients with undetectable viremia over long-term highly active antiretroviral therapy (HAART) shows that quantitation permits the continued monitoring of HAART in patients with invisibility.